RealFeedApp beta
Top science & technology news, August 31, 2026
- Understanding ChatGPT Work
OpenAI launched ChatGPT Work, available only to paid subscribers, with two versions: cloud and local.
- A quantum generative model for in silico clinical trials using scarce training datasets
Model uses quantum computers to generate realistic in silico patients with limited data. Tested on Myelodysplastic Syndrome patient database.
- AI-Written Code Is Still *Your* Code
AI-generated code is becoming common, but understanding it remains a challenge. The article highlights the importance of comprehension when writing software.
- Electra Therapeutics Seeks Nasdaq Listing for Phase 2/3 Expansion
Electra plans 2026 IPO to fund immunology and cancer drug development.
- CRISPRi Screen Identifies PQLC2 as Lysosomal pH Regulator
PQLC2 loss prevents lysosomal acidification, impacting tau homeostasis in neurons.
- AstraZeneca's Heart Failure Drug Shows Promise in Phase 2 Trial
AstraZeneca's relaxin agonist improved cardiac function in two patient groups in phase 2b trial.
- LLM inference with FHE encryption achieves 1s/token interactive performance
Interactive FHE-LLM inference runs at 1.05 seconds per token with exact output matching, while full encryption takes 6 minutes per token.
- Brain Aging Timeline in Major Depression
Patients with MDD show a brain age 1.4–2.5 years older than healthy controls.
- U.S. imposes drone and robot tariffs as China gains dominance
U.S. imposes tariffs on drones and robot components, citing national security. Chinese manufacturers dominate the market with competitive pricing.
- Static Evaluation of Model Switching in LLM Agents Scores the Wrong World
The study reveals that static evaluation of model switching in LLM agents fails to account for dynamic changes, affecting accuracy.
- FDA clears software that quantifies amyloid in Alzheimer’s
NeuroQuant automates amyloid quantification, replacing radiologist judgment with standardized numbers.
- New method for accurate surface phenotyping of biological specimens
The platform reduces surface area measurement errors by 11-43% across different biological samples.
- Bacterial Lipoic Acid Protein Ligase A Enhances Mitochondrial Function in Mammals
Enzyme LplA from bacteria improves mitochondrial metabolism in mammals. Study shows it works more efficiently than mammalian analogs.
- Aging clocks can predict mortality risk and age-related conditions
Existing clinical trial data can help build aging clocks that predict higher age in older individuals, linked to increased mortality risk.
- LLM-Guided UAV Search with Semantic Reasoning
UAV navigation system uses LLMs to prioritize search areas based on natural language instructions.
- Small serine recombinases are markers for antiphage defense system discovery
Study identifies small serine recombinases as genetic markers linked to antiphage defense systems, enabling their discovery across bacterial phyla.
- Learning a threat converges on the circuit processing innate threat
Both innate and learned threats converge on the same modulatory mechanisms, but with different access to neural pathways.
- Mission Therapeutics and NeuraLight partner on Parkinson’s biomarkers
NeuraLight’s platform will provide objective measures to quantify neural pathway function in Mission’s MTX325 trial.
- Neighbourhood Deprivation and Neurobiological Risk
Neighbourhood deprivation is linked to reduced cortical and subcortical brain volume across multiple age groups.
- Two evolutionary histories in one nucleus: genome remodeling and allelic regulation underlying heterosis in hybrid oil palm
Hybrid oil palm integrates two subgenomes, enhancing yield and disease resistance through genomic remodeling.
